Pharmaceutical compositions for transdermal administration of anti-inflammatory agents
申请人:——
公开号:US20030152611A1
公开(公告)日:2003-08-14
The invention concerns a pharmaceutical composition for transdermal administration comprising: a polymeric release matrix capable of forming a soft film after drying, selected among cellulose polymers or copolymers, said matrix being present at a concentration not exceeding 6% of the composition weight; an active principle selected among the group of non-steroid anti-inflammatory agents comprising at least a metal carboxylic or carboxitate group; a transcutaneous absorption promoter of the active principle; water; and at least a physiologically acceptable non-aqueous solvent capable of dissolving the release matrix, the active principle and transcutaneous absorption promoter and to be rapidly eliminated by evaporation in contact with the skin.
该发明涉及一种用于经皮给药的制药组合物,包括:一种聚合物释放基质,能够在干燥后形成软膜,所述基质从纤维素聚合物或共聚物中选择,所述基质的浓度不超过组合物重量的6%;选择自非甾体抗炎药物组中的活性成分,该组成分至少包括一种金属羧基或羧酸盐基团;活性成分的经皮吸收促进剂;水;以及至少一种生理上可接受的非水溶剂,能够溶解释放基质、活性成分和经皮吸收促进剂,并在与皮肤接触时通过蒸发迅速被消除。